Therapy News and Research

RSS

State highlights: Calif. hospital accused of patient dumping; Wash. mental health changes

Los Angeles City Atty. Mike Feuer has filed a lawsuit accusing Glendale Adventist Medical Center of dumping mentally ill and disabled homeless patients on L.A.'s skid row over the last four years. The six-page complaint, filed Wednesday in Los Angeles County Superior Court, said the hospital improperly transported elderly and dependent patients to the downtown Los Angeles neighborhood, a 50-block area "known for extreme poverty, homelessness, rampant sale and use of illegal drugs and violent crime" (Holland, 8/22).

26 Aug 2014

Risk factors for heart disease are higher in Saxony-Anhalt

A lack of education, an unhealthy diet, and unemployment go straight to the heart—quite literally, because all three range among the risks that cause ischemic heart disease or contribute to its development.

26 Aug 2014

Scientists pave way for improved tools to predict and monitor cancer

Scientists have shown how to better identify and measure vital molecules that control cell behaviour - paving the way for improved tools for diagnosis, prediction and monitoring of cancer.

From The University of Manchester 26 Aug 2014

Repurposing anti-depressant medication to target new pathway may help combat medulloblastoma

An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children.

26 Aug 2014

Drug to kill limited type of cancer cells with DNA repair defects could treat leukaemia

A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.

26 Aug 2014

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly is a chronic, life-threatening disease triggered by a benign tumour of the pituitary gland causing excessive growth hormone release. Oversupply of growth hormone stimulates liver, fat and kidney cells to produce excess levels of Insulin-Like Growth Factor I (IGFI), which causes abnormal growth of the bones of the hands, face and feet and bodily organs.

26 Aug 2014

UT Southwestern researchers discover crucial link between high insulin levels and obesity pathways

UT Southwestern Medical Center researchers have identified a crucial link between high levels of insulin and pathways that lead to obesity, a finding that may have important implications when treating diabetes.

26 Aug 2014

Researchers find why certain glioblastomas become drug resistance

Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy.

26 Aug 2014

Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Spring Bioscience (Spring), a member of the Roche Group, today announced the launch of its PD-L1 (SP142) rabbit monoclonal immunohistochemistry (IHC) antibody.

25 Aug 2014

Researchers develop new integrated approach to pinpoint genetic "drivers" of cancer

UNC Lineberger Comprehensive Cancer Center researchers have developed a new integrated approach to pinpoint the genetic "drivers" of cancer, uncovering eight genes that could be viable for targeted breast cancer therapy.

25 Aug 2014

Researchers find more selective therapies for cancer

Thanks to important discoveries in basic and clinical research and technological advances, the fight against cancer has mobilized into a complex offensive spanning multiple fronts.

25 Aug 2014

Emdeon Easy Save: A simplified copay coupon assistance program for retail pharmacies

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced the launch of Emdeon Easy Save™ for retail pharmacies.

25 Aug 2014

Researchers examine impact of BIM deletion on survival outcomes of advanced NSCLC patients

Bcl-2-like protein 11 (BIM) deletion in advanced non-small cell lung cancer (NSCLC) is associated with shorter progression free survival (PFS) in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) or chemotherapy treated Asian patients.

25 Aug 2014

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting.

25 Aug 2014

ProMedica participates in innovative research into development of non-invasive treatment for BPH

ProMedica is participating in innovative research into the development of a safe, non-invasive treatment for BPH or enlarged prostate. BPH can block the flow of urine out of the bladder and cause bladder, urinary tract or kidney problems.

23 Aug 2014

Study finds a host of new clues on gene-environment interactions in Crohn's disease

A new study finds a wide range of epigenetic changes-alterations in DNA across the genome that may be related to key environmental exposures-in children with Crohn's disease (CD), reports Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America.

23 Aug 2014

Viewpoints: 'Raw judicial politics' on health law; Texas abortion trial; suicide and gender

The Affordable Care Act -- Obamacare -- has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge -- this one aimed at the supposed effect of a single word in the 900-page statute -- was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).

22 Aug 2014

Young girls with vulvitis may be at increased risk of developing urinary tract infections

Young girls with an intense, red, itchy rash on their outer genital organs may be at increased risk of developing urinary tract infections (UTIs), according to new research from Wake Forest Baptist Medical Center. The treatment may be as simple as better hygiene and avoiding potential irritants such as bubble baths and swimming pools.

22 Aug 2014

Physician develops new device to treat stroke more effectively

A new device developed by a physician at the University of Arkansas for Medical Sciences and a researcher at the University of Arkansas at Little Rock could soon be available to treat stroke more effectively.

22 Aug 2014

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

The Perelman School of Medicine at the University of Pennsylvania has launched the Penn Center for Advanced Retinal and Ocular Therapeutics (CAROT) to build on its previous success developing novel therapies for the personalized diagnosis and treatment of retinal and ocular disorders.

22 Aug 2014

Therapy News and Research

State highlights: Calif. hospital accused of patient dumping; Wash. mental health changes

Risk factors for heart disease are higher in Saxony-Anhalt

Scientists pave way for improved tools to predict and monitor cancer

Repurposing anti-depressant medication to target new pathway may help combat medulloblastoma

Drug to kill limited type of cancer cells with DNA repair defects could treat leukaemia

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

UT Southwestern researchers discover crucial link between high insulin levels and obesity pathways

Researchers find why certain glioblastomas become drug resistance

Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Researchers develop new integrated approach to pinpoint genetic "drivers" of cancer

Researchers find more selective therapies for cancer

Emdeon Easy Save: A simplified copay coupon assistance program for retail pharmacies

Researchers examine impact of BIM deletion on survival outcomes of advanced NSCLC patients

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

ProMedica participates in innovative research into development of non-invasive treatment for BPH

Study finds a host of new clues on gene-environment interactions in Crohn's disease

Viewpoints: 'Raw judicial politics' on health law; Texas abortion trial; suicide and gender

Young girls with vulvitis may be at increased risk of developing urinary tract infections

Physician develops new device to treat stroke more effectively

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News